# FDA recall D-0592-2024

> **Zydus Pharmaceuticals (USA) Inc** · Class III · drug recall initiated 2024-07-02.

## Product

Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-7; (b) 5x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-5; Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534,

## Reason for recall

Cross contamination with other products.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0592-2024
- **Recalling firm:** Zydus Pharmaceuticals (USA) Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-07-02
- **Report date:** 2024-07-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Pennington, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0592-2024

## Citation

> AI Analytics. FDA recall D-0592-2024. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0592-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*